BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 9785493)

  • 21. Dynamics of African horse sickness virus nucleic acid and antibody in horses following immunization with a commercial polyvalent live attenuated vaccine.
    Weyer CT; Grewar JD; Burger P; Joone C; Lourens C; MacLachlan NJ; Guthrie AJ
    Vaccine; 2017 Apr; 35(18):2504-2510. PubMed ID: 28341113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serological response of foals to polyvalent and monovalent live-attenuated African horse sickness virus vaccines.
    Crafford JE; Lourens CW; Smit TK; Gardner IA; MacLachlan NJ; Guthrie AJ
    Vaccine; 2014 Jun; 32(29):3611-6. PubMed ID: 24814557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular and serological surveillance of African horse sickness virus in eastern and central Saudi Arabia.
    Hemida MG; Alhammadi M; Daleb A; Alnaeem A
    Rev Sci Tech; 2017 Dec; 36(3):889-898. PubMed ID: 30160693
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recombinant baculovirus-synthesized African horsesickness virus (AHSV) outer-capsid protein VP2 provides protection against virulent AHSV challenge.
    Roy P; Bishop DH; Howard S; Aitchison H; Erasmus B
    J Gen Virol; 1996 Sep; 77 ( Pt 9)():2053-7. PubMed ID: 8811002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Further studies on the efficacy of an inactivated African horse sickness serotype 4 vaccine.
    House JA; Lombard M; Dubourget P; House C; Mebus CA
    Vaccine; 1994 Feb; 12(2):142-4. PubMed ID: 8147096
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preparation of recombinant African horse sickness virus VP7 antigen via a simple method and validation of a VP7-based indirect ELISA for the detection of group-specific IgG antibodies in horse sera.
    Maree S; Paweska JT
    J Virol Methods; 2005 Apr; 125(1):55-65. PubMed ID: 15737417
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular epidemiology of African horse sickness virus based on analyses and comparisons of genome segments 7 and 10.
    Zientara S; Sailleau C; Plateau E; Moulay S; Mertens PP; Crucière C
    Arch Virol Suppl; 1998; 14():221-34. PubMed ID: 9785509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vaccination of horses with a recombinant modified vaccinia Ankara virus (MVA) expressing African horse sickness (AHS) virus major capsid protein VP2 provides complete clinical protection against challenge.
    Alberca B; Bachanek-Bankowska K; Cabana M; Calvo-Pinilla E; Viaplana E; Frost L; Gubbins S; Urniza A; Mertens P; Castillo-Olivares J
    Vaccine; 2014 Jun; 32(29):3670-4. PubMed ID: 24837765
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protective efficacy of multivalent replication-abortive vaccine strains in horses against African horse sickness virus challenge.
    Lulla V; Losada A; Lecollinet S; Kerviel A; Lilin T; Sailleau C; Beck C; Zientara S; Roy P
    Vaccine; 2017 Jul; 35(33):4262-4269. PubMed ID: 28625521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serological survey of African horse sickness in selected districts of Jimma zone, Southwestern Ethiopia.
    Bitew M; Andargie A; Bekele M; Jenberie S; Ayelet G; Gelaye E
    Trop Anim Health Prod; 2011 Dec; 43(8):1543-7. PubMed ID: 21465102
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Use of the immunoenzyme test ELISA-NS3 to distinguish horses infected by African horsesickness virus from vaccinated horses].
    Idrissi Bougrine S; Fassi Fihri O; el Harrak M; Fassi Fehri MM
    Rev Sci Tech; 1999 Dec; 18(3):618-26. PubMed ID: 10588005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ns1 is a key protein in the vaccine composition to protect Ifnar(-/-) mice against infection with multiple serotypes of African horse sickness virus.
    de la Poza F; Calvo-Pinilla E; López-Gil E; Marín-López A; Mateos F; Castillo-Olivares J; Lorenzo G; Ortego J
    PLoS One; 2013; 8(7):e70197. PubMed ID: 23894615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of a Microsphere-based Immunoassay for Serological Detection of African Horse Sickness Virus and Comparison with Other Diagnostic Techniques.
    Sánchez-Matamoros A; Beck C; Kukielka D; Lecollinet S; Blaise-Boisseau S; Garnier A; Rueda P; Zientara S; Sánchez-Vizcaíno JM
    Transbound Emerg Dis; 2016 Dec; 63(6):e270-e277. PubMed ID: 25693720
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of a mouse model system, coding assignments and identification of the genome segments controlling virulence of African horse sickness virus serotypes 3 and 8.
    O'Hara RS; Meyer AJ; Burroughs JN; Pullen L; Martin LA; Mertens PP
    Arch Virol Suppl; 1998; 14():259-79. PubMed ID: 9785512
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A single dose of African horse sickness virus (AHSV) VP2 based vaccines provides complete clinical protection in a mouse model.
    Aksular M; Calvo-Pinilla E; Marín-López A; Ortego J; Chambers AC; King LA; Castillo-Olivares J
    Vaccine; 2018 Nov; 36(46):7003-7010. PubMed ID: 30309744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The immunogenicity of recombinant vaccines based on modified Vaccinia Ankara (MVA) viruses expressing African horse sickness virus VP2 antigens depends on the levels of expressed VP2 protein delivered to the host.
    Calvo-Pinilla E; Gubbins S; Mertens P; Ortego J; Castillo-Olivares J
    Antiviral Res; 2018 Jun; 154():132-139. PubMed ID: 29678552
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the pathogenicity of African Horsesickness (AHS) isolates in vaccinated animals.
    von Teichman BF; Smit TK
    Vaccine; 2008 Sep; 26(39):5014-21. PubMed ID: 18682269
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of African horse sickness virus NS3 protein, expressed in bacteria, as a marker to differentiate infected from vaccinated horses.
    Laviada MD; Roy P; Sánchez-Vizcaíno JM; Casal JI
    Virus Res; 1995 Oct; 38(2-3):205-18. PubMed ID: 8578859
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PCR detection of African horse sickness virus serogroup based on genome segment three sequence analysis.
    Aradaib IE
    J Virol Methods; 2009 Jul; 159(1):1-5. PubMed ID: 19442836
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serologic markers in early stages of African horse sickness virus infection.
    Martínez-Torrecuadrada JL; Díaz-Laviada M; Roy P; Sánchez C; Vela C; Sánchez-Vizcaíno JM; Casal JI
    J Clin Microbiol; 1997 Feb; 35(2):531-5. PubMed ID: 9003637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.